| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Heineman Thomas Charles is a Chief Medical Officer at ONCOLYTICS BIOTECH INC. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $255K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | ONCY Oncolytics Biotech Inc | Chief Medical Officer | Buy | 12,132 | $0.83 | $10,033.16 | +4.5% | - | - |